{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:15:08Z","timestamp":1789604108593,"version":"build-2803163510"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,1,13]],"date-time":"2009-01-13T00:00:00Z","timestamp":1231804800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1007\/s00109-008-0433-0","type":"journal-article","created":{"date-parts":[[2009,1,12]],"date-time":"2009-01-12T08:29:44Z","timestamp":1231748984000},"page":"385-399","source":"Crossref","is-referenced-by-count":19,"title":["Regional administration of oncolytic Echovirus 1 as a novel therapy for the peritoneal dissemination of gastric cancer"],"prefix":"10.1007","volume":"87","author":[{"given":"Erin S.","family":"Haley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gough G.","family":"Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R.","family":"Carlton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren R.","family":"Shafren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,1,13]]},"reference":[{"key":"433_CR1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74\u2013108","journal-title":"CA Cancer J Clin"},{"key":"433_CR2","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3748\/wjg.v12.i3.354","volume":"12","author":"KD Crew","year":"2006","unstructured":"Crew KD, Neugut AI (2006) Epidemiology of gastric cancer. World J Gastroenterol 12:354\u2013362","journal-title":"World J Gastroenterol"},{"key":"433_CR3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","volume":"88","author":"B Sadeghi","year":"2000","unstructured":"Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, Fontaumard E, Brachet A, Caillot JL, Faure JL, Porcheron J, Peix JL, Francois Y, Vignal J, Gilly FN (2000) Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88:358\u2013363","journal-title":"Cancer"},{"key":"433_CR4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10120-007-0436-5","volume":"10","author":"Y Fujiwara","year":"2007","unstructured":"Fujiwara Y, Doki Y, Taniguchi H, Sohma I, Takiguchi S, Miyata H, Yamasaki M, Monden M (2007) Genetic detection of free cancer cells in the peritoneal cavity of the patient with gastric cancer: present status and future perspectives. Gastric Cancer 10:197\u2013204","journal-title":"Gastric Cancer"},{"key":"433_CR5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/1097-0142(19890115)63:2<364::AID-CNCR2820630228>3.0.CO;2-V","volume":"63","author":"DZ Chu","year":"1989","unstructured":"Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC (1989) Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 63:364\u2013367","journal-title":"Cancer"},{"key":"433_CR6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1349-7006.2006.00350.x","volume":"98","author":"Y Yonemura","year":"2007","unstructured":"Yonemura Y, Endo Y, Obata T, Sasaki T (2007) Recent advances in the treatment of peritoneal dissemination of gastrointestinal cancers by nucleoside antimetabolites. Cancer Sci 98:11\u201318","journal-title":"Cancer Sci"},{"key":"433_CR7","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3748\/wjg.14.1159","volume":"14","author":"HA Al-Shammaa","year":"2008","unstructured":"Al-Shammaa HA, Li Y, Yonemura Y (2008) Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. World J Gastroenterol 14:1159\u20131166","journal-title":"World J Gastroenterol"},{"key":"433_CR8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2174\/1566523024605582","volume":"2","author":"JC Bell","year":"2002","unstructured":"Bell JC, Garson KA, Lichty BD, Stojdl DF (2002) Oncolytic viruses: programmable tumour hunters. Curr Gene Ther 2:243\u2013254","journal-title":"Curr Gene Ther"},{"key":"433_CR9","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nrc1750","volume":"5","author":"KA Parato","year":"2005","unstructured":"Parato KA, Senger D, Forsyth PA, Bell JC (2005) Recent progress in the battle between oncolytic viruses and tumours. Nat Rev Cancer 5:965\u2013976","journal-title":"Nat Rev Cancer"},{"key":"433_CR10","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s001090000092","volume":"78","author":"JJ Bennett","year":"2000","unstructured":"Bennett JJ, Kooby DA, Delman K, McAuliffe P, Halterman MW, Federoff H, Fong Y (2000) Antitumor efficacy of regional oncolytic viral therapy for peritoneally disseminated cancer. J Mol Med 78:166\u2013174","journal-title":"J Mol Med"},{"key":"433_CR11","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/sj.cgt.7700510","volume":"9","author":"JJ Bennett","year":"2002","unstructured":"Bennett JJ, Delman KA, Burt BM, Mariotti A, Malhotra S, Zager J, Petrowsky H, Mastorides S, Federoff H, Fong Y (2002) Comparison of safety, delivery, and efficacy of two oncolytic herpes viruses (G207 and NV1020) for peritoneal cancer. Cancer Gene Ther 9:935\u2013945","journal-title":"Cancer Gene Ther"},{"key":"433_CR12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1089\/104303404323142051","volume":"15","author":"SF Stanziale","year":"2004","unstructured":"Stanziale SF, Stiles BM, Bhargava A, Kerns SA, Kalakonda N, Fong Y (2004) Oncolytic herpes simplex virus-1 mutant expressing green fluorescent protein can detect and treat peritoneal cancer. Hum Gene Ther 15:609\u2013618","journal-title":"Hum Gene Ther"},{"key":"433_CR13","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1158\/1078-0432.CCR-05-2576","volume":"12","author":"L Kangasniemi","year":"2006","unstructured":"Kangasniemi L, Kiviluoto T, Kanerva A, Raki M, Ranki T, Sarkioja M, Wu H, Marini F, Hockerstedt K, Isoniemi H, Alfthan H, Stenman UH, Curiel DT, Hemminki A (2006) Infectivity-enhanced adenoviruses deliver efficacy in clinical samples and orthotopic models of disseminated gastric cancer. Clin Cancer Res 12:3137\u20133144","journal-title":"Clin Cancer Res"},{"key":"433_CR14","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1158\/1535-7163.MCT-07-2134","volume":"7","author":"X Huang","year":"2008","unstructured":"Huang X, Zhuang L, Cao Y, Gao Q, Han Z, Tang D, Xing H, Wang W, Lu Y, Xu G, Wang S, Zhou J, Ma D (2008) Biodistribution and kinetics of the novel selective oncolytic adenovirus M1 after systemic administration. Mol Cancer Ther 7:1624\u20131632","journal-title":"Mol Cancer Ther"},{"key":"433_CR15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1158\/1078-0432.CCR-0690-3","volume":"10","author":"DR Shafren","year":"2004","unstructured":"Shafren DR, Au GG, Nguyen T, Newcombe NG, Haley ES, Beagley L, Johansson ES, Hersey P, Barry RD (2004) Systemic therapy of malignant human melanoma tumors by a common cold-producing enterovirus, Coxsackievirus A21. Clin Cancer Res 10:53\u201360","journal-title":"Clin Cancer Res"},{"key":"433_CR16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2141.2007.06550.x","volume":"137","author":"G Au","year":"2007","unstructured":"Au G, Lincz LF, Enno A, Shafren DR (2007) Oncolytic Coxsackievirus A21 as a novel therapy for multiple myeloma. Br J Haematol 137:133\u2013141","journal-title":"Br J Haematol"},{"key":"433_CR17","doi-asserted-by":"crossref","unstructured":"Skelding KA, Barry RD, Shafren DR (2008) Systemic targeting of metastatic human breast tumor xenografts by Coxsackievirus A21. Breast Cancer Res Treat. doi: 10.1007\/s10549-008-9899-2","DOI":"10.1007\/s10549-008-9899-2"},{"key":"433_CR18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/pros.20741","volume":"68","author":"LJ Berry","year":"2008","unstructured":"Berry LJ, Au GG, Barry RD, Shafren DR (2008) Potent oncolytic activity of human enteroviruses against human prostate cancer. The Prostate 68:577\u2013587","journal-title":"The Prostate"},{"key":"433_CR19","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/ijc.20866","volume":"115","author":"DR Shafren","year":"2005","unstructured":"Shafren DR, Sylvester D, Johansson ES, Campbell IG, Barry RD (2005) Oncolysis of human ovarian cancers by echovirus type 1. Int J Cancer 115:320\u2013328","journal-title":"Int J Cancer"},{"key":"433_CR20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3109\/15419069409004455","volume":"2","author":"JM Bergelson","year":"1994","unstructured":"Bergelson JM, St John NF, Kawaguchi S, Pasqualini R, Berdichevsky F, Hemler ME, Finberg RW (1994) The I domain is essential for echovirus 1 interaction with VLA-2. Cell Adhes Commun 2:455\u2013464","journal-title":"Cell Adhes Commun"},{"key":"433_CR21","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1126\/science.1553561","volume":"255","author":"JM Bergelson","year":"1992","unstructured":"Bergelson JM, Shepley MP, Chan BM, Hemler ME, Finberg RW (1992) Identification of the integrin VLA-2 as a receptor for echovirus 1. Science 255:1718\u20131720","journal-title":"Science"},{"key":"433_CR22","first-page":"809","volume":"18","author":"T Kawamura","year":"2001","unstructured":"Kawamura T, Endo Y, Yonemura Y, Nojima N, Fujita H, Fujimura T, Obata T, Yamaguchi T, Sasaki T (2001) Significance of integrin alpha2\/beta1 in peritoneal dissemination of a human gastric cancer xenograft model. Int J Oncol 18:809\u2013815","journal-title":"Int J Oncol"},{"key":"433_CR23","first-page":"310","volume":"123","author":"N Koike","year":"1997","unstructured":"Koike N, Todoroki T, Komano H, Shimokama T, Ban S, Ohno T, Fukao K, Watanabe T (1997) Invasive potentials of gastric carcinoma cell lines: role of alpha 2 and alpha 6 integrins in invasion. J Cancer Res Clin Oncol 123:310\u2013316","journal-title":"J Cancer Res Clin Oncol"},{"key":"433_CR24","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/bjc.1996.556","volume":"74","author":"S Nishimura","year":"1996","unstructured":"Nishimura S, Chung YS, Yashiro M, Inoue T, Sowa M (1996) Role of alpha 2 beta 1- and alpha 3 beta 1-integrin in the peritoneal implantation of scirrhous gastric carcinoma. Br J Cancer 74:1406\u20131412","journal-title":"Br J Cancer"},{"key":"433_CR25","first-page":"21","volume":"5","author":"T Matsuoka","year":"2000","unstructured":"Matsuoka T, Yashiro M, Nishimura S, Inoue T, Fujihara T, Sawada T, Kato Y, Seki S, Hirakawa-Ys Chung K (2000) Increased expression of alpha2beta1-integrin in the peritoneal dissemination of human gastric carcinoma. Int J Mol Med 5:21\u201325","journal-title":"Int J Mol Med"},{"key":"433_CR26","doi-asserted-by":"crossref","first-page":"34594","DOI":"10.1074\/jbc.M706600200","volume":"282","author":"MT Lin","year":"2007","unstructured":"Lin MT, Chang CC, Lin BR, Yang HY, Chu CY, Wu MH, Kuo ML (2007) Elevated expression of Cyr61 enhances peritoneal dissemination of gastric cancer cells through integrin alpha2beta1. J Biol Chem 282:34594\u201334604","journal-title":"J Biol Chem"},{"key":"433_CR27","doi-asserted-by":"crossref","first-page":"11632","DOI":"10.1074\/jbc.M312441200","volume":"279","author":"L Xing","year":"2004","unstructured":"Xing L, Huhtala M, Pietiainen V, Vuorinen K, Marjomaki V, Heino J, Johnson MS, Hyypia T, Cheng RH (2004) Structural and functional analysis of integrin a2I domain interaction with echovirus 1. J Biol Chem 279:11632\u201311638","journal-title":"J Biol Chem"},{"key":"433_CR28","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1172\/JCI116555","volume":"92","author":"JM Bergelson","year":"1993","unstructured":"Bergelson JM, Chan BM, Finberg RW, Hemler ME (1993) The integrin VLA-2 binds echovirus 1 and extracellular matrix ligands by different mechanisms. J Clin Invest 92:232\u2013239","journal-title":"J Clin Invest"},{"key":"433_CR29","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1021\/jm070063t","volume":"50","author":"J Kapyla","year":"2007","unstructured":"Kapyla J, Pentikainen OT, Nyronen T, Nissinen L, Lassander S, Jokinen J, Lahti M, Marjamaki A, Johnson MS, Heino J (2007) Small molecule designed to target metal binding site in the alpha2I domain inhibits integrin function. J Med Chem 50:2742\u20132746","journal-title":"J Med Chem"},{"key":"433_CR30","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3181\/00379727-81-19964","volume":"81","author":"JL Melnick","year":"1952","unstructured":"Melnick JL, Aagren K (1952) Poliomyelitis and coxsackie viruses isolated from normal infants in Egypt. Proc Soc Exp Biol Med 81:621\u2013624","journal-title":"Proc Soc Exp Biol Med"},{"key":"433_CR31","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1172\/JCI105166","volume":"44","author":"RB Couch","year":"1965","unstructured":"Couch RB, Cate TR, Gerone PJ, Fleet WF, Lang DJ, Griffith WR, Knight V (1965) Production of illness with a small-particle aerosol of Coxsackie A21. J Clin Invest 44:535\u2013542","journal-title":"J Clin Invest"},{"key":"433_CR32","first-page":"685","volume-title":"Field\u2019s virology","author":"VR Rancaniello","year":"2001","unstructured":"Rancaniello VR (2001) Picornaviridae: the viruses and their replication. In: Fields BN, Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (eds) Field\u2019s virology. Lippincott Williman and Wilkins, Philadelphia, pp 685\u2013722"},{"key":"433_CR33","first-page":"169","volume-title":"Techniques in experimental virology","author":"RM Dougherty","year":"1964","unstructured":"Dougherty RM (1964) Animal virus titration techniques. In: Harris RJC (ed) Techniques in experimental virology. Academic, New York, pp 169\u2013223"},{"key":"433_CR34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000150012","volume":"28","author":"GE Yousef","year":"1987","unstructured":"Yousef GE, Brown IN, Mowbray JF (1987) Derivation and biochemical characterization of an enterovirus group-specific monoclonal antibody. Intervirology 28:163\u2013170","journal-title":"Intervirology"},{"key":"433_CR35","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1128\/CDLI.2.3.385-386.1995","volume":"2","author":"A Samuelson","year":"1995","unstructured":"Samuelson A, Forsgren M, Sallberg M (1995) Characterization of the recognition site and diagnostic potential of an enterovirus group-reactive monoclonal antibody. Clin Diagn Lab Immunol 2:385\u2013386","journal-title":"Clin Diagn Lab Immunol"},{"key":"433_CR36","first-page":"65","volume":"35","author":"ZG Dikmen","year":"2005","unstructured":"Dikmen ZG, Gellert G, Dogan P, Mason R, Antich P, Richer E, Wright WE, shay JW (2005) A new diagnostic system in cancer research: bioluminescent imaging (BLI). Turk J Med Sci 35:65\u201370","journal-title":"Turk J Med Sci"},{"key":"433_CR37","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/BF02483952","volume":"28","author":"H Ura","year":"1998","unstructured":"Ura H, Denno R, Hirata K, Yamaguchi K, Yasoshima T (1998) Separate functions of alpha2beta1 and alpha3beta1 integrins in the metastatic process of human gastric carcinoma. Surg Today 28:1001\u20131006","journal-title":"Surg Today"},{"key":"433_CR38","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1006\/viro.1997.8692","volume":"235","author":"S Zhang","year":"1997","unstructured":"Zhang S, Racaniello VR (1997) Persistent echovirus infection of mouse cells expressing the viral receptor VLA-2. Virology 235:293\u2013301","journal-title":"Virology"},{"key":"433_CR39","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1091\/mbc.e04-01-0070","volume":"15","author":"V Pietiainen","year":"2004","unstructured":"Pietiainen V, Marjomaki V, Upla P, Pelkmans L, Helenius A, Hyypia T (2004) Echovirus 1 endocytosis into caveosomes requires lipid rafts, dynamin II, and signaling events. Mol Biol Cell 15:4911\u20134925","journal-title":"Mol Biol Cell"},{"key":"433_CR40","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.canlet.2007.02.002","volume":"254","author":"MJ Vaha-Koskela","year":"2007","unstructured":"Vaha-Koskela MJ, Heikkila JE, Hinkkanen AE (2007) Oncolytic viruses in cancer therapy. Cancer Lett 254:178\u2013216","journal-title":"Cancer Lett"},{"key":"433_CR41","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1349-7006.2005.00054.x","volume":"96","author":"K Yanagihara","year":"2005","unstructured":"Yanagihara K, Takigahira M, Tanaka H, Komatsu T, Fukumoto H, Koizumi F, Nishio K, Ochiya T, Ino Y, Hirohashi S (2005) Development and biological analysis of peritoneal metastasis mouse models for human scirrhous stomach cancer. Cancer Sci 96:323\u2013332","journal-title":"Cancer Sci"},{"key":"433_CR42","first-page":"893","volume":"16","author":"K Kaneko","year":"2000","unstructured":"Kaneko K, Yano M, Tsujinaka T, Morita S, Taniguchi M, Fujiwara Y, Doki Y, Inoue M, Shiozaki H, Monden M (2000) Establishment of a visible peritoneal micrometastatic model from a gastric adenocarcinoma cell line by green fluorescent protein. Int J Oncol 16:893\u2013898","journal-title":"Int J Oncol"},{"key":"433_CR43","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.1158\/0008-5472.CAN-05-3259","volume":"66","author":"K Yanagihara","year":"2006","unstructured":"Yanagihara K, Takigahira M, Takeshita F, Komatsu T, Nishio K, Hasegawa F, Ochiya T (2006) A photon counting technique for quantitatively evaluating progression of peritoneal tumor dissemination. Cancer Res 66:7532\u20137539","journal-title":"Cancer Res"},{"key":"433_CR44","first-page":"65","volume":"36","author":"T Motoyama","year":"1986","unstructured":"Motoyama T, Hojo H, Watanabe H (1986) Comparison of seven cell lines derived from human gastric carcinomas. Acta Pathol Jpn 36:65\u201383","journal-title":"Acta Pathol Jpn"},{"key":"433_CR45","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/jgm.700","volume":"7","author":"K Nakano","year":"2005","unstructured":"Nakano K, Todo T, Zhao G, Yamaguchi K, Kuroki S, Cohen JB, Glorioso JC, Tanaka M (2005) Enhanced efficacy of conditionally replicating herpes simplex virus (G207) combined with 5-fluorouracil and surgical resection in peritoneal cancer dissemination models. J Gene Med 7:638\u2013648","journal-title":"J Gene Med"},{"key":"433_CR46","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1745-6150-1-6","volume":"1","author":"AS Novozhilov","year":"2006","unstructured":"Novozhilov AS, Berezovskaya FS, Koonin EV, Karev GP (2006) Mathematical modeling of tumor therapy with oncolytic viruses: regimes with complete tumor elimination within the framework of deterministic models. Biol Direct 1:6","journal-title":"Biol Direct"},{"key":"433_CR47","first-page":"3501","volume":"61","author":"D Wodarz","year":"2001","unstructured":"Wodarz D (2001) Viruses as antitumor weapons: defining conditions for tumor remission. Cancer Res 61:3501\u20133507","journal-title":"Cancer Res"},{"key":"433_CR48","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/jmv.10352","volume":"70","author":"A Karttunen","year":"2003","unstructured":"Karttunen A, Poyry T, Vaarala O, Ilonen J, Hovi T, Roivainen M, Hyypia T (2003) Variation in enterovirus receptor genes. J Med Virol 70:99\u2013108","journal-title":"J Med Virol"},{"key":"433_CR49","first-page":"1","volume":"55","author":"N Khetsuriani","year":"2006","unstructured":"Khetsuriani N, Lamonte-Fowlkes A, Oberst S, Pallansch MA (2006) Enterovirus surveillance\u2014United States, 1970\u20132005. MMWR Surveill Summ 55:1\u201320","journal-title":"MMWR Surveill Summ"},{"key":"433_CR50","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1046\/j.1365-2168.2000.01360.x","volume":"87","author":"CH Yoo","year":"2000","unstructured":"Yoo CH, Noh SH, Shin DW, Choi SH, Min JS (2000) Recurrence following curative resection for gastric carcinoma. Br J Surg 87:236\u2013242","journal-title":"Br J Surg"},{"key":"433_CR51","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1007\/s00464-002-8766-1","volume":"17","author":"P Ziprin","year":"2003","unstructured":"Ziprin P, Ridgway PF, Peck DH, Darzi AW (2003) Laparoscopic enhancement of tumour cell binding to the peritoneum is inhibited by anti-intercellular adhesion molecule-1 monoclonal antibody. Surg Endosc 17:1812\u20131817","journal-title":"Surg Endosc"},{"key":"433_CR52","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/SLA.0b013e3181588583","volume":"247","author":"SJ Oosterling","year":"2008","unstructured":"Oosterling SJ, van der Bij GJ, Bogels M, ten Raa S, Post JA, Meijer GA, Beelen RH, van Egmond M (2008) Anti-beta1 integrin antibody reduces surgery-induced adhesion of colon carcinoma cells to traumatized peritoneal surfaces. Ann Surg 247:85\u201394","journal-title":"Ann Surg"},{"key":"433_CR53","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jso.21075","volume":"98","author":"IK Jung","year":"2008","unstructured":"Jung IK, Kim MC, Kim KH, Kwak JY, Jung GJ, Kim HH (2008) Cellular and peritoneal immune response after radical laparoscopy-assisted and open gastrectomy for gastric cancer. J Surg Oncol 98:54\u201359","journal-title":"J Surg Oncol"},{"key":"433_CR54","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/MOU.0b013e3282f517fc","volume":"18","author":"N Hegarty","year":"2008","unstructured":"Hegarty N, Dasgupta P (2008) Immunological aspects of minimally invasive oncologic surgery. Curr Opin Urol 18:129\u2013133","journal-title":"Curr Opin Urol"},{"key":"433_CR55","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/sj.cgt.7701033","volume":"14","author":"X Fu","year":"2007","unstructured":"Fu X, Tao L, Zhang X (2007) An oncolytic virus derived from type 2 herpes simplex virus has potent therapeutic effect against metastatic ovarian cancer. Cancer Gene Ther 14:480\u2013487","journal-title":"Cancer Gene Ther"},{"key":"433_CR56","first-page":"4656","volume":"62","author":"KW Peng","year":"2002","unstructured":"Peng KW, TenEyck CJ, Galanis E, Kalli KR, Hartmann LC, Russell SJ (2002) Intraperitoneal therapy of ovarian cancer using an engineered measles virus. Cancer Res 62:4656\u20134662","journal-title":"Cancer Res"},{"key":"433_CR57","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1525-0016(03)00200-4","volume":"8","author":"A Kanerva","year":"2003","unstructured":"Kanerva A, Zinn KR, Chaudhuri TR, Lam JT, Suzuki K, Uil TG, Hakkarainen T, Bauerschmitz GJ, Wang M, Liu B, Cao Z, Alvarez RD, Curiel DT, Hemminki A (2003) Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus. Mol Ther 8:449\u2013458","journal-title":"Mol Ther"},{"key":"433_CR58","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1749-0774.2002.tb00108.x","volume":"15","author":"M Sunamura","year":"2002","unstructured":"Sunamura M, Oonuma M, Motoi F, Abe H, Saitoh Y, Hoshida T, Ottomo S, Horii A, Matsuno S (2002) Gene therapy for pancreatic cancer targeting the genomic alterations of tumor suppressor genes using replication-selective oncolytic adenovirus. Hum Cell 15:138\u2013150","journal-title":"Hum Cell"},{"key":"433_CR59","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1158\/1535-7163.MCT-07-0176","volume":"6","author":"K Guse","year":"2007","unstructured":"Guse K, Ranki T, Ala-Opas M, Bono P, Sarkioja M, Rajecki M, Kanerva A, Hakkarainen T, Hemminki A (2007) Treatment of metastatic renal cancer with capsid-modified oncolytic adenoviruses. Mol Cancer Ther 6:2728\u20132736","journal-title":"Mol Cancer Ther"},{"key":"433_CR60","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1378\/chest.63.3.457","volume":"63","author":"LA Schleissner","year":"1973","unstructured":"Schleissner LA, Portnoy B (1973) Spectrum of ECHO virus 1 disease in a young diabetic. CHEST 63:457\u2013459","journal-title":"CHEST"},{"key":"433_CR61","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1128\/AAC.00227-06","volume":"50","author":"RA Desmond","year":"2006","unstructured":"Desmond RA, Accortt NA, Talley L, Villano SA, Soong SJ, Whitley RJ (2006) Enteroviral meningitis: natural history and outcome of pleconaril therapy. Antimicrob Agents Chemother 50:2409\u20132414","journal-title":"Antimicrob Agents Chemother"},{"key":"433_CR62","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1086\/522866","volume":"196","author":"GM McQuillan","year":"2007","unstructured":"McQuillan GM, Kruszon-Moran D, Hyde TB, Forghani B, Bellini W, Dayan GH (2007) Seroprevalence of measles antibody in the US population, 1999\u20132004. J Infect Dis 196:1459\u20131464","journal-title":"J Infect Dis"},{"key":"433_CR63","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1128\/CDLI.11.2.351-357.2004","volume":"11","author":"E Nwanegbo","year":"2004","unstructured":"Nwanegbo E, Vardas E, Gao W, Whittle H, Sun H, Rowe D, Robbins PD, Gambotto A (2004) Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of The Gambia, South Africa, and the United States. Clin Diagn Lab Immunol 11:351\u2013357","journal-title":"Clin Diagn Lab Immunol"},{"key":"433_CR64","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/jama.296.8.964","volume":"296","author":"F Xu","year":"2006","unstructured":"Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, Nahmias AJ, Berman SM, Markowitz LE (2006) Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. Jama 296:964\u2013973","journal-title":"Jama"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-008-0433-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-008-0433-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-008-0433-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T15:12:04Z","timestamp":1589469124000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-008-0433-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,13]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["433"],"URL":"https:\/\/doi.org\/10.1007\/s00109-008-0433-0","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,13]]}}}